1 / 1

Suppl. Fig. 3

Suppl. Fig. 3. # 2. # 1. A. # 1. B. 42%. AD. # 2. 44%. AD/FasL. # 3. 39%. AD/FasL/ a -Fas. Analysis of BM-MSC adipogenesis.

weldon
Download Presentation

Suppl. Fig. 3

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Suppl. Fig. 3 # 2 # 1 A # 1 B 42% AD # 2 44% AD/FasL # 3 39% AD/FasL/ a-Fas Analysis of BM-MSC adipogenesis. A) Human BM-MSC batches #1, #2 and #3 were cultured in adipogenic medium for 14 days; the percentage of adipocytes out of the total cell number was determined by counting Oil Red O-positive cells out of methylene blue-stained cells by light microscopy (10x magnification). 20 random fields were examined. B) BM-MSCs (batch #1 and #2 represented) were treated with 25 ng/ml FasL in a-MEM for 2 days. On day 2 a-MEM was replaced with adipogenic medium (AD); AD-supplemented with 25 ng/ml FasL (AD/FasL); or AD supplemented with 25 ng/ml FasL and ZB4 anti-Fas antibody added 20 min before FasL (AD/FasL/a-Fas). All treatments were applied throughout the differentiation period (14 days). Oil Red O and methylene blue staining 14 days from induction of adipogenesis (day 16) (magnification 10x).

More Related